insights_auto
Outlook: 15.0% bullish·15.0% bearish
Go to analysischevron_right
BSX:NYSE
Boston Scientific Corp
$42.60
arrow_downward
-1.46%(-0.63) 1D
$42.77
arrow_upward
+0.39% (+0.17)bedtimeAfter hours
Closed: Oct 2, 4:00:04 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BSX...
Open
$43.32
High
$43.44
Low
$41.94
Mkt. cap
61.74B
Avg. vol.
21.40M
Volume
18.31M
P/E ratio
17.27
52-wk high
$105.65
52-wk low
$41.94
EPS
$2.47
Beta
0.58
Shares outstanding
1.45B
No. of employees
59K
Open
$43.32
High
$43.44
Low
$41.94
Mkt. cap
61.74B
Avg. vol.
21.40M
Volume
18.31M
P/E ratio
17.27
52-wk high
$105.65
52-wk low
$41.94
EPS
$2.47
Beta
0.58
Shares outstanding
1.45B
No. of employees
59K
News stories
From web sources and news partners
The Globe and Mail
·
15 hours ago
Boston Scientific (BSX) Receives a Buy from RBC Capital
The Globe and Mail
·
1 day ago
Bernstein Keeps Their Buy Rating on Boston Scientific (BSX)
Profile
Boston Scientific Corporation is an American biotechnology and biomedical engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.
The company is known for developing the Taxus Stent, a drug-eluting stent that is used to open clogged arteries.
BSC is headquartered in Marlborough, Massachusetts and incorporated in Delaware. Wikipedia
About Boston Scientific Corp
CEOMichael F. Mahoney
Employees59K
FoundedJun 29, 1979
HeadquartersMarlborough, Massachusetts, United States
SectorMedical device
Websitebostonscientific.com